EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

COVID-19 and myocarditis: a systematic review and overview of current challenges

Teresa Castiello, Georgios Georgiopoulos, Gherardo Finocchiaro, Monaco Claudia, Andrea Gianatti, Dimitrios Delialis, Alberto Aimo iD, Sanjay Prasad

Heart Failure Reviews · 2022-01 · 27 (1) · 251-261

DOI: 10.1007/s10741-021-10087-9 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Heart Failure Reviews, online erschienen am 24.03.2021. Verfasst von Teresa Castiello und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Croydon Health Service, London, UK. Hauptthemen laut MEDLINE: COVID-19, Myocarditis. Die Arbeit wurde bisher 157-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scuola Superiore Sant'Anna.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myocardial inflammation in COVID-19 has been documented. Its pathogenesis is not fully elucidated, but the two main theories foresee a direct role of ACE2 receptor and a hyperimmune response, which may also lead to isolated presentation of COVID-19-mediated myocarditis. The frequency and prognostic impact of COVID-19-mediated myocarditis is unknown. This review aims to summarise current evidence on this topic. We performed a systematic review of MEDLINE and Cochrane Library (1/12/19–30/09/20). We also searched clinicaltrials.gov for unpublished studies testing therapies with potential implication for COVID-19-mediated cardiovascular complication. Eligible studies had laboratory confirmed COVID-19 and a clinical and/or histological diagnosis of myocarditis by ESC or WHO/ISFC criteria. Reports of 38 cases were included (26 male patients, 24 aged < 50 years). The first histologically proven case was a virus-negative lymphocytic myocarditis; however, biopsy evidence of myocarditis secondary to SARS-CoV-2 cardiotropism has been recently demonstrated. Histological data was found in 12 cases (8 EMB and 4 autopsies) and CMR was the main imaging modality to confirm a diagnosis of myocarditis (25 patients). There was a substantial variability in biventricular systolic function during the acute episode and in therapeutic regimen used. Five patients died in hospital. Cause-effect relationship between SARS-CoV-2 infection and myocarditis is difficult to demonstrate. However, current evidence demonstrates myocardial inflammation with or without direct cardiomyocyte damage, suggesting different pathophysiology mechanisms responsible of COVID-mediated myocarditis. Established clinical approaches should be pursued until future evidence support different actions. Large multicentre registries are advisable to elucidate further.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19MyocarditisHumansMaleMyocytes, CardiacRegistriesSARS-CoV-2

Stichwörter der Autor:innen

2019nCoVCOVID-19Cardiac damageCardiac injuryCoronavirusMyocardial damageMyocarditisSARS-CoV-2

Autor:innen und Institutionen

  • Department of Cardiology, Croydon Health Service, London, UK.
  • School of Biomedical Engineering and Imaging Sciences, Kings College London, London, UK.
  • The Kennedy Institute of Rheumatology University of Oxford, Oxford, UK.
  • Anatomic Pathology Unit, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Department of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • Scuola Superiore Sant'Anna, Pisa, Italy. a.aimo@santannapisa.it.

ORCID-Profile: Alberto Aimo

Förderung

  • Scuola Superiore Sant'Anna

Zitieren

APA

Castiello, T., Georgiopoulos, G., Finocchiaro, G., Claudia, M., Gianatti, A., Delialis, D., Aimo, A., & Prasad, S. (2022). COVID-19 and myocarditis: a systematic review and overview of current challenges. Heart Failure Reviews, 27(1), 251-261. https://doi.org/10.1007/s10741-021-10087-9

Vancouver

Castiello T, Georgiopoulos G, Finocchiaro G, Claudia M, Gianatti A, Delialis D, et al. COVID-19 and myocarditis: a systematic review and overview of current challenges. Heart Failure Reviews. 2022;27(1):251-261. doi:10.1007/s10741-021-10087-9

BibTeX
@article{Castiello2022,
  author = {Castiello, Teresa and Georgiopoulos, Georgios and Finocchiaro, Gherardo and Claudia, Monaco and Gianatti, Andrea and Delialis, Dimitrios and Aimo, Alberto and Prasad, Sanjay},
  title = {COVID-19 and myocarditis: a systematic review and overview of current challenges},
  journal = {Heart Failure Reviews},
  year = {2022},
  volume = {27},
  number = {1},
  pages = {251--261},
  doi = {10.1007/s10741-021-10087-9}
}
Kostenlos starten →